Skip to main content
Home
About
Our Purpose
Our People
Leadership
Board of Directors
Policies
Legal Information
Careers
MultiStem
Overview
Mechanisms of Action
Clinical Pipeline
Clinical Trials
Ischemic Stroke
Acute Respiratory Distress Syndrome (ARDS)
Trauma
Acute Myocardial Infarction
Scientific Publications
Investors
Overview
Fact Sheet
Events
Stock Information
Financial Information
Governance Documents
Corporate Presentation
Annual Shareholder Meeting
Business Development
Overview
SIFU
Animal Health
Indications for Partnership
Neurological
Cardiovascular
Inflammatory & Immune
News & Media
Overview
Press Releases
In the News
Events
Video
Social Media
Contact Us
Event Details
Home
About
Our Purpose
Our People
Leadership
Board of Directors
Policies
Legal Information
Careers
MultiStem
Overview
Mechanisms of Action
Clinical Pipeline
Clinical Trials
Ischemic Stroke
Acute Respiratory Distress Syndrome (ARDS)
Trauma
Acute Myocardial Infarction
Scientific Publications
Investors
Overview
Fact Sheet
Events
Stock Information
Financial Information
Governance Documents
Corporate Presentation
Annual Shareholder Meeting
Business Development
Overview
SIFU
Animal Health
Indications for Partnership
Neurological
Cardiovascular
Inflammatory & Immune
News & Media
Overview
Press Releases
In the News
Events
Video
Social Media
Contact Us
Athersys Second Quarter 2022 Results Conference Call
August 11, 2022
04:30 PM ET
Click
here
to register
Add to Calendar
Add to Apple Calendar
Add to Google Calendar
Add to Microsoft Outlook
Add to iCalendar
Webcast
Press Release
(opens in new window)
PDF
185 KB